Kala Bio, Inc. filed a prospectus supplement pursuant to Rule 424(b) under the Securities Act of 1933 regarding an offering of securities under its existing Form S-3 registration statement. This 8-K filing provides the legal opinion from Haynes and Boone, LLP concerning the validity of the securities being offered. Kala Bio, Inc. is a biotechnology company.
